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Abstract
Background: Ubiquitin (E3) ligases interact with specific ubiquitin conjugating (E2) enzymes to
ubiquitinate particular substrate proteins. As the combination of E2 and E3 dictates the type and
biological consequence of ubiquitination, it is important to understand the basis of specificity in
E2:E3 interactions. The E3 ligase CHIP interacts with Hsp70 and Hsp90 and ubiquitinates client
proteins that are chaperoned by these heat shock proteins. CHIP interacts with two types of E2
enzymes, UbcH5 and Ubc13-Uev1a. It is unclear, however, why CHIP binds these E2 enzymes
rather than others, and whether CHIP interacts preferentially with UbcH5 or Ubc13-Uev1a, which
form different types of polyubiquitin chains.
Results: The 2.9 Å crystal structure of the CHIP U-box domain complexed with UbcH5a shows
that CHIP binds to UbcH5 and Ubc13 through similar specificity determinants, including a key S-P-
A motif on the E2 enzymes. The determinants make different relative contributions to the overall
interactions between CHIP and the two E2 enzymes. CHIP undergoes auto-ubiquitination by
UbcH5 but not by Ubc13-Uev1a. Instead, CHIP drives the formation of unanchored polyubiquitin
by Ubc13-Uev1a. CHIP also interacts productively with the class III E2 enzyme Ube2e2, in which
the UbcH5- and Ubc13-binding specificity determinants are highly conserved.
Conclusion: The CHIP:UbcH5a structure emphasizes the importance of specificity determinants
located on the long loops and central helix of the CHIP U-box, and on the N-terminal helix and
loops L4 and L7 of its cognate E2 enzymes. The S-P-A motif and other specificity determinants
define the set of cognate E2 enzymes for CHIP, which likely includes several Class III E2 enzymes.
CHIP's interactions with UbcH5, Ube2e2 and Ubc13-Uev1a are consistent with the notion that
Ubc13-Uev1a may work sequentially with other E2 enzymes to carry out K63-linked
polyubiquitination of CHIP substrates.
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Background
Ubiquitination is a key posttranslational modification
that is involved in most aspects of cellular homeostasis,
signalling and regulation. In ubiquitination, sequential
action of E1 (ubiquitin-activating), E2 (ubiquitin-conju-
gating) and E3 (ubiquitin ligase) proteins act sequentially
to promote attachment of the 76 amino-acid polypeptide
ubiquitin to a substrate protein[1,2]. Ubiquitin is
attached to the substrate through an isopeptide bond
between the C-terminus of ubiquitin and the ε-amino
group of a substrate lysine. E1 enzymes transfer ubiquitin
to the active site cysteine of an E2 enzyme [3]. E2
enzymes, in turn, bind to E3 ligases, which contain either
HECT domains or a member of the structurally similar
RING, PHD-like and U-box domain superfamily [4-6]. E3
ligases also contain other domains that directly or indi-
rectly bind substrate proteins. E3 ligases thus bring
together ubiquitin-conjugated E2 enzymes and particular
substrates, and also catalyze ubiquitin transfer to substrate
lysines [4]. In the absence of substrates, some E3 ligases
can promote the attachment of ubiquitin to one of their
own lysines, in a process termed "autoubiquitination" [7-
9].
Ubiquitination can result in the addition of a single ubiq-
uitin (monoubiquitination) but also in the addition of
successive ubiquitins to the first (polyubiquitination)
[10]. Successive ubiquitins are linked through one of the
seven ubiquitin surface lysines. Modification by a K48-
linked polyubiquitin chain targets the substrate for pro-
teasomal degradation, the intracellular fate commonly
associated with ubiquitination [11]. Other polyubiquitin
chains and monoubiquitin play roles in trafficking, DNA
repair, signal transduction, transcriptional regulation and
other processes [12,13].
E2 enzymes exhibit high similarity in sequence and struc-
ture [14]. There are several dozen E2 enzymes and hun-
dreds of E3 ligases, which carry out ubiquitination in
different combinations. As the identity of the E2 enzyme
recruited by an E3 ligase to a particular substrate crucially
influences the type and consequences of the ubiquitina-
tion, it is important to characterize the structural and bio-
chemical parameters that govern the specificity of E2:E3
interactions.
The C-terminus of Hsp70 interacting protein (CHIP) is a
homodimeric ubiquitin ligase that links chaperone func-
tion with the degradation of misfolded or unstable pro-
teins [15,16]. As such, CHIP plays a key role in protein
quality control, serving as a disposal mechanism for con-
formationally intractable proteins that might otherwise
overwhelm the chaperone system. CHIP binds to C-termi-
nal motifs found in the chaperones Hsp70 and Hsp90.
CHIP has three domains: an N-terminal TPR (tetratr-
icopeptide repeat) domain through which it binds Hsp70
or Hsp90, a middle helical domain that mediates CHIP
dimerization [17], and a C-terminal U-box domain that
binds specific E2 enzymes [5]. By recruiting a cognate E2
enzyme, CHIP promotes ubiquitination of numerous
labile client proteins that are chaperoned by Hsp70 or
Hsp90 [18-20]. These clients include proto-oncogene
products, kinases, nuclear hormone receptors, and aggre-
gation-prone proteins, such as α-synuclein and tau, that
are involved in neurodegenerative diseases [15,16,21].
Two E2 enzymes, UbcH5 and Ubc13, have been identified
as cognates for CHIP [18,20,22]. "UbcH5" refers collec-
tively to three highly homologous E2 enzymes, UbcH5a,
b and c (88% identical, 95% similar). While the UbcH5
enzymes were previously thought to carry out K48-linked
ubiquitination exclusively, recent studies have shown that
they can form mixed-linkage polyubiquitin chains in vitro
with several E3 ligases, including CHIP [23]. Recently,
Pearl and coworkers showed that CHIP also interacts with
Ubc13-Uev1a [22,24], a heterodimeric E2 enzyme that
exclusively forms K63-linked chains [25]. K63-linked
chains are primarily associated with trafficking and sub-
strate regulation (through the mediation of new protein-
protein interactions) rather than degradation [26]. The
crystal structure of Ubc13-Uev1a bound to the U-box of
CHIP shows that Ubc13 interacts with the CHIP U-box,
while neither subunit of the Ubc13-Uev1a heterodimer
contacts the CHIP-TPR or dimerization domains [22].
Interaction between CHIP and these two different E2
enzymes likely results in different types of polyubiquitina-
tion and different biological outcomes. As UbcH5 and
Ubc13 are similar in sequence and structure, it is unclear
whether and how CHIP distinguishes between these E2
enzymes. To obtain additional insights into CHIP specifi-
city, we solved the crystal structure of Zebrafish UbcH5a
bound to the CHIP U-box domain. Despite an overall
structural similarity, CHIP exhibits differences in the
details of individual interactions in the UbcH5a and
Ubc13-Uev1a complexes, as well as in the ability of the
respective enzymes to carry out CHIP autoubiquitination
(self-ubiquitination of CHIP in the absence of Hsp70 or
Hsp90). The structures of the two complexes allow us to
further define a set of specificity determinants required for
interaction with CHIP. Based on these determinants, we
identify several class III E2 enzymes as an additional, third
group of cognate E2 enzymes for CHIP. As the first E3
ligase to be structurally characterized in complex with two
different E2 enzymes, CHIP may serve as a useful model
for understanding the basis of specificity in other E2:E3
interactions.BMC Structural Biology 2008, 8:26 http://www.biomedcentral.com/1472-6807/8/26
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Results
Structure of the CHIP U-box: UbcH5a complex
We previously investigated the interaction between CHIP
and UbcH5b using NMR and site-directed mutagenesis
[27]. This allowed us to identify respective binding inter-
faces on each protein and to propose a model for the
CHIP U-box:UbcH5b complex. The model, however, was
ambiguous with respect to specific interactions mediated
by particular main-chain and side-chain groups, espe-
cially those involving the prominent L4 and L7 loops on
the E2 enzyme. To obtain a more accurate understanding
of how CHIP binds to members of the UbcH5 family, we
screened full-length human and Zebrafish CHIP, as well
as their respective U-box domains, for cocrystallization
with human and Zebrafish UbcH5a, UbcH5b and
UbcH5c. We crystallized a complex of the Zebrafish CHIP
U-box and UbcH5a and solved its structure to 2.9 Å reso-
lution by molecular replacement (see Methods). Statistics
for the structure solution are listed in Table 1.
The crystal asymmetric unit contains a back-to-back U-
box dimer, with each U-box bound to an UbcH5a mole-
cule (Figure 1A). The U-box conformation and dimeriza-
tion mode are essentially identical to those in previously
described structures of free CHIP (rmsd < 0.4 Å), empha-
sizing that the U-box undergoes negligible conforma-
tional change upon binding to an E2 enzyme. The CHIP
U-box structure is characteristic of the RING/PHD-like/U-
box fold superfamily [4-6]. It consists of a small β-sheet, a
central  α-helix (termed CHIP-α9, as the other two
domains of CHIP contain eight other alpha helices) and a
C-terminal helix (CHIP-α10) that participates in U-box
dimerization. The U-box also has two prominent loops,
CHIP-L1 and CHIP-L2, which, together with CHIP-α9,
comprise the interaction site for E2 enzymes [22].
While several structures of UbcH5 family E2 enzymes
have been solved previously [28,29], this is the first to be
solved in complex with an E3 ligase domain. UbcH5a
adopts the characteristic fold exhibited by all E2 enzyme
catalytic cores, consisting of a central β-sheet flanked by 4
helices. The N-terminal α-helix (UbcH5a-α1) and two
prominent loops, UbcH5a-L4 and UbcH5a-L7, comprise
most of one side the protein and interact with the CHIP
U-box (Figure 1A), contacting a hydrophobic groove
formed by the interface of CHIP-L1, CHIP-L2 and CHIP-
α9. The interface buries ~700 Å2 of solvent-accessible sur-
face area. The overall CHIP U-box:UbcH5a complex
resembles the structures of the CHIP U-box: Ubc13-Uev1a
complex [22] and the complex of the c-Cbl RING domain
with the E2 enzyme UbcH7 [30].
Full-length CHIP is an asymmetric homodimer, in which
the conformation of one monomer is such that its TPR
domain occludes the U-box domain of the same mono-
mer; the CHIP dimer thus contains only one E2 binding
site [22]. We superimposed the U-box:UbcH5a complex
onto the structure of full-length mouse CHIP (Figure 1B).
The model of the CHIP:UbcH5 complex reemphasizes
that E2 interactions with CHIP are mediated only through
the U-box domain, while no contacts are made between
the E2 and the helical or TPR domains of the CHIP dimer.
Analysis of interface between CHIP U-box and UbcH5a
Key interactions between the CHIP U-box and UbcH5a
are shown in Figure 2. (For compatibility with our in vitro
ubiquitination assays, which were carried out using
human rather than zebrafish CHIP, we refer to all CHIP
residues according to the numbering in the human pro-
tein). The interactions are arranged around a central
hydrophobic patch, in which the sidechain of UbcH5a-
F62 protrudes into a concave surface formed by aliphatic
portions of sidechains from both loops and helix α9 of
the U-box (Figure 2A). The phenyl ring of UbcH5a-F62
also stacks against the guanidinium group of CHIP-R263,
Table 1: Crystallographic and Refinement Statistics
CHIP U-box: UbcH5a complex
Data Collection
Space group P212121
Unit cell
a, b, c (Å) 79.0, 93.4, 144.0
α,β,γ (°) 90, 90, 90
No. molecules/asymmetric unit 2 CHIP, 2 UbcH5a
Resolution (Å) 55.00-2.90 (3.00-2.90)a
Unique reflections 24283
Completeness (%) 99.9 (100)
Redundancy 3.40 (3.42)
I/σ 8.5 (1.6)
Rmerge(%)b 8.0 (46.6)
Refinement
Resolution (Å) 53.2-2.90 (3.08-2.90)
Rwork(%)c 24.0
Rfree(%)d 27.2
Protein atoms 3518
Waters 4
Other atoms 3
Average B factor (Å2)6 5 . 0
r.m.s.d. – bond lengths (Å) 0.007
r.m.s.d. – bond angles (°) 1.4
r.m.s.d. – dihedrals (°) 23.4
r.m.s.d. – improper angles (°) 1.1
Ramachandran plot (%)
Most favored and allowed 97.6
Generously Allowed 2.4
Disallowed 0.0
PDB ID code 2 OXQ
aStatistics for the highest resolution shell are shown in parentheses.
bRmerge = Σ|Ii-<Ii>|/Σ|Ii|
cRwork = Σh||Fobs(h)|-k|Fcalc(h)||/ΣhFobs(h)
dRfree is the R factor calculated for 5% of reflections, excluded from 
refinementBMC Structural Biology 2008, 8:26 http://www.biomedcentral.com/1472-6807/8/26
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which is held in position by a salt bridge with CHIP-E259
(Figure 2B). These two large sidechains thus form the
"back wall" of a primarily hydrophobic dimple in the
CHIP U-box surface, into which UbcH5a protrudes.
UbcH5a-F62 is flanked by other aliphatic residues
(UbcH5a-P61, P95, A96), which contribute to the hydro-
phobic interaction area. An additional interaction is
formed by planar stacking of the aromatic sidechain of
CHIP-F237 against the guanidinium group [31] of
UbcH5a-R5, which leaves the arginine sidechain free to
participate in an extensive intra-UbcH5a polar network
(Figure 2A, C).
The abovementioned interactions are flanked by polar
interactions (Figure 2C), among which hydrogen bonds
between the sidechains of UbcH5a-R5, UbcH5a-S94, and
CHIP-R272 with complementary main chain groups are
prominent. Several additional interactions, such as the
one between UbcH5a-K8 and the CHIP-F237 carbonyl
oxygen, are likely to be weak, as they are present in one of
the U-box: UbcH5a complexes in the crystal asymmetric
unit but not in the other. In addition, there are several
charged residues on UbcH5-α1 and CHIP-L1 (labelled
with question marks in Figure 2B) that are near enough to
each other to potentially engage in salt bridge interac-
tions. The relevant sidechains, however, exhibit subopti-
mal interaction geometries or actually point away from
their putative partner residues, suggesting that the corre-
sponding salt bridges are weak or disfavoured.
In the absence of Hsp70/Hsp90 and a chaperone-bound
client, CHIP itself is ubiquitinated by UbcH5 family E2
enzymes [20,24]. CHIP autoubiquitination is an effective
reporter of a productive interaction between CHIP and
UbcH5 enzymes. We previously mutagenized the surface
of the CHIP U-box to identify residues important for its
interaction with UbcH5 family E2 enzymes, as gauged by
in vitro CHIP autoubiquitination assays and western blot-
ting with anti-ubiquitin antibody [27]. We have now car-
ried out ELISA-based assays (see Methods) in Nickel-NTA
coated microplates to quantitate autoubiquitination of
His-tagged human CHIP by human UbcH5b (which is
identical to UbcH5a in the CHIP-interacting region). Our
results confirm the key importance of the hydrophobic
CHIP residues lining the intersection of the L1 and L2
loops and helix α9, including CHIP-I235, H260 and
V264, as CHIP is autoubiquitinated poorly or not at all by
the corresponding alanine mutants (see below). Similarly,
flanking interactions mediated by F237 and R272 are cru-
cial for productive CHIP:UbcH5 interactions, as the corre-
sponding alanine mutants also eliminate CHIP
autoubiquitination (see below).
Comparison between CHIP:UbcH5a and CHIP:Ubc13-
Uev1a complexes
Many of the interactions shown in Figure 2 are also con-
served in the complex between CHIP and Ubc13-Uev1a
(Figure 3A). Superimposition of the UbcH5a:CHIP U-box
and Ubc13:CHIP U-box complexes (Figure 3B) suggests
that the interaction surfaces in the two complexes are sim-
ilar, though there are several detailed differences that may
influence the relative strengths of the interactions. The α1
helices of the two E2 enzymes are the most divergent in
terms of overall structure, but this difference does not
Structure of the CHIP:UbcH5a complex Figure 1
Structure of the CHIP:UbcH5a complex. A. Asymmetric unit of the crystallized zebrafish CHIP U-box: UbcH5a complex, 
showing the U-box dimer (blue) with two bound UbcH5a molecules (yellow). Secondary structure elements that mediate the 
interaction between the U-boxes and UbcH5a are labelled in blue or black for the U-boxes and UbcH5a respectively. Active 
site cysteines of the UbcH5a molecules are shown in ball-and-stick representation and labelled. B. Model of the CHIP:UbcH5a 
complex, CHIP, built by superimposing the U-box dimer and one UbcH5a molecule from the structure shown in panel A onto 
the crystal structure of murine CHIP, PDB:2C2L [22]. The TPR and helical domains of the two CHIP monomers are coloured 
light and dark grey. One TPR domain is behind the rest of the molecule and is left unlabelled for clarity.BMC Structural Biology 2008, 8:26 http://www.biomedcentral.com/1472-6807/8/26
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translate into large differences in the locations of the
CHIP-interacting residues, such as UbcH5a-R5/Ubc13-
R7, on these helices (Figure 3B).
Since UbcH5 and Ubc13-Uev1a form different types of
polyubiquitin chains [23,25], we investigated whether
mutations that prevented autoubiquitination of CHIP by
UbcH5 have similar effects on Ubc13-Uev1a. We initially
Details of the interaction between UbcH5a and the CHIP U-box Figure 2
Details of the interaction between UbcH5a and the CHIP U-box. The view in panel C is zoomed out from that in pan-
els A and B. For clarity, only side-chain or main-chain atoms of some residues are shown. Panels on the right show molecular 
surface representations of the CHIP U-box. A. Closeup of the hydrophobic packing between UbcH5a (yellow) and CHIP 
(blue). The interacting secondary structure elements and residues are labelled in black (UbcH5a) or blue (CHIP). B. "Back" 
view of the complex emphasizing the hydrophobic packing between UbcH5a-loop L2 (the F62 sidechain) and the CHIP U-box. 
C. Polar interactions between UbcH5a and CHIP. Likely hydrogen bonds or salt bridges are shown as dotted lines. Acidic and 
basic side chains that are in proximity but not close enough or in the correct geometry to form salt bridges are marked with 
question marks.BMC Structural Biology 2008, 8:26 http://www.biomedcentral.com/1472-6807/8/26
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tried to detect autoubiquitination of His-CHIP by Ubc13-
Uev1a in Nickel-NTA plates as described above for
UbcH5, but observed no CHIP autoubiquitination above
background (Figure 4A, column marked "*Ubc13-
Uev1a"). Several previous studies have suggested that
CHIP catalyzes the formation of unanchored K63-linked
polyubiquitin chains by Ubc13-Uev1a, but that these
chains are not conjugated to CHIP itself [24,30]. We
reconfirmed this by western blotting of in vitro ubiquitina-
tion assays. CHIP promoted the formation of polyubiqui-
tin chains by Ubc13-Uev1a, detected using anti-Ubiquitin
antibody. No higher-molecular weight species indicative
of polyubiquitinated CHIP, however, were detectable by
western blotting with anti-CHIP (Figure 4B).
Our initial ELISA assay selected exclusively for His-tagged
CHIP conjugated to Flag-ubiquitin. We therefore carried
out a second assay using a mixture of His- and Flag-tagged
ubiquitins to detect polyubiquitin chains that were not
conjugated to CHIP. Our results indeed confirm that
CHIP catalyzes Ubc13-Uev1a-mediated formation of
unanchored, mixed Flag- and His-tagged ubiquitin chains
that were readily quantified (Figure 4A). However, despite
the structural similarity between the CHIP:UbcH5a and
CHIP:Ubc13 interfaces (Figure 3B), several mutations that
do not catalyze ubiquitination with UbcH5b are substan-
tially active with Ubc13-Uev1a. Of the mutants tested,
only CHIP-I235A is inactive with both E2 enzymes (Fig-
ure 4A).
To explore why Ubc13-Uev1a is less sensitive to many of
the mutations that eliminate productive interactions
between UbcH5 and CHIP, we investigated the two most
obvious differences in the CHIP:UbcH5a and
CHIP:Ubc13 interfaces (Figure 3B). First, Ubc13-M64 is
located in the same position as UbcH5-F62. Second, a salt
bridge between Ubc13-R14 and CHIP-D229 is not con-
served in the CHIP:UbcH5a complex; instead, UbcH5a-
D12 is the equivalent of Ubc13-R14. We mutagenized
these sites to investigate their importance for CHIP:E2
interactions. Surprisingly, Ubc13 is largely insensitive to
mutations at the M64 position. In contrast, UbcH5a does
not tolerate a methionine at the F62 position (Figure 4C).
The interaction between R14 and CHIP-D229 also con-
tributes to binding between Ubc13 and CHIP, as Ubc13-
R14D is inactive in polyubiquitin chain formation (Figure
4C). Similarly, the CHIP-D229A mutant is less active in
polyubiquitin chain formation by Ubc13-Uev1a than any
CHIP mutants other than CHIP-I235A (Figure 4A). In
contrast, the D229A mutation has little effect on CHIP
autoubiquitination by UbcH5b.
Thus, M64 is not required to anchor the hydrophobic
interface between Ubc13 and CHIP, possibly because
Ubc13 has at an additional compensating salt bridge to
buttress its interaction with CHIP. Indeed, the hydropho-
bic interface is less important overall for the Ubc13:CHIP
interaction, and the CHIP-H260A and CHIP-V264A
mutants also exhibited partial activity with Ubc13-Uev1a.
Interaction between Ubc13 and the CHIP U-box Figure 3
Interaction between Ubc13 and the CHIP U-box. Only the main-chain or side-chain atoms of some residues are shown 
for clarity. Hydrogen bonds and salt bridges are shown as dotted lines. A. Interactions between Ubc13 (white) and the CHIP 
U-box (cyan), from PDB:2C2V [22]. B. Superimposition of the UbcH5a:CHIP U-box and Ubc13:CHIP U-box complexes 
(UbcH5a in yellow, Ubc13 in white). As the conformations of the CHIP U-box backbone and interface residues are almost 
identical between the structures, only the U-box from the Ubc13:CHIP complex is shown. Several key interacting residues are 
shown explicitly. The red dashed circles indicate two interaction sites that differ between the two E2 enzymes.BMC Structural Biology 2008, 8:26 http://www.biomedcentral.com/1472-6807/8/26
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These data suggest that the detailed binding energetics dif-
fer between the CHIP:UbcH5a and CHIP:Ubc13-Uev1a
complexes, in terms of the relative importance of individ-
ual interactions for overall binding.
Influence of S-P-A motif in E2 enzymes on interaction with 
CHIP
One of the points of most intimate contacts between
CHIP and UbcH5a or Ubc13-Uev1a is located at the inter-
face of the CHIP U-box and loop L7 of the E2 enzymes
(Figure 2). On this loop, the motif S-P-A (residues 94–96
of UbcH5a or residues 96–98 of Ubc13) makes a hydro-
gen bond with the carbonyl group of CHIP-P269 and van
der Waals contacts with CHIP-H260, V264 and V270. As
previously noted by Pearl and coworkers, the first position
within this motif is unlikely to tolerate bulkier sidechains
than serine, as these would clash with the surface of the
CHIP U-box [22]. Previous studies indeed suggest that E2
enzymes that do not contain the S-P-A motif are not cog-
nate E2 enzymes for CHIP (Table 2).
We examined the sequences of human E2 enzymes for
those containing S-P-A motifs on loop L7, and with no
residues at other positions that would obviously prevent
interaction with the CHIP U-box. Several Class III E2
enzymes, Ube2e1, Ube2e2 and Ube3e3, fulfilled these cri-
teria. Class III E2 enzymes, by definition, contain a N-ter-
minal sequences that precede an E2 catalytic domain. The
Ube2e1-3 enzymes, which contain 40–50 residue N-ter-
minal extensions [32], undergo nuclear translocation after
being charged with ubiquitin from E1 [33]. While their N-
terminal regions differ, their catalytic domains are highly
homologous (95% identical, 99% similar). We tested full-
length Ube2e2 as well as its catalytic domain (Ube2e2-
cat) for polyubiquitin chain formation in the presence of
CHIP by western blotting and by the ELISA-based ubiqui-
tination assay (Figure 5). Like UbcH5, Ube2e2cat autou-
biquitinates CHIP. Based on the very high homology
between the Ube2e1-3 catalytic domains, it is likely that
Ube2e1 and Ube2e3 are also cognate E2 enzymes for
CHIP.
We used another E2 enzyme, UbcH7, to investigate
whether the S-P-A motif is sufficient for conferring com-
patibility with CHIP. UbcH7 contains a Lysine at the posi-
tion equivalent to the Serine of the S-P-A motif. We tested
both wild-type UbcH7 and UbcH7-K96S for CHIP autou-
biquitination (Figure 5B). Surprisingly, neither carried
out polyubiquitination with CHIP, suggesting that the
presence of an S-P-A motif in an E2 enzyme is necessary
but not sufficient for productive interaction with CHIP.
Discussion
Understanding the factors governing selectivity between
E2 enzymes and E3 ligases is important for several pur-
Mutagenesis of CHIP:E2 interaction surfaces Figure 4
Mutagenesis of CHIP:E2 interaction surfaces. A. In 
vitro ubiquitination measurements of CHIP with UbcH5 or 
Ubc13-Uev1a carried out using an ELISA-based assay. Wild-
type or mutant His-CHIP bound to Nickel-NTA coated 
microplates was autoubiquitinated with FLAG-Ubiquitin in 
the presence of UbcH5b (dark grey bars). Mixed His- and 
Flag-tagged polyubiquitin chains were formed in Nickel-NTA 
coated microplates in the presence of untagged CHIP and 
Ubc13-Uev1a (light grey bars). The white bar ("*Ubc13-
Uev1a") represents (minimal) autoubiquitination of His-CHIP 
by FLAG-Ubiquitin in the presence of Ubc13-Uev1a. "-CHIP" 
designates negative controls carried out with no CHIP in the 
reactions. Data are in arbitrary units and were normalized by 
the values measured for the respective E2 enzymes with 
wild-type CHIP. B. Autoubiquitination of CHIP in the pres-
ence of UbcH5 but not Ubc13-Uev1a, probed by western 
blotting. Anti-ubiquitin staining confirms the formation of 
polyubiquitin chains by Ubc13-Uev1a in a CHIP-dependent 
manner. Anti-CHIP staining shows that a fraction of CHIP is 
ubiquitinated (higher-molecular weight bands) in the pres-
ence of UbcH5 but not Ubc13-Uev1a. C. Ubiquitination 
measurements of wild-type CHIP with wild-type and mutant 
UbcH5 or Ubc13-Uev1a, as described for panel A.
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poses: 1) identifying or predicting which E2:E3 pairs gov-
ern a particular ubiquitin-linked pathway; 2) engineering
E2:E3 pairs that can be used to identify substrates targeted
by a particular E2:E3 combination; 3) rationalizing the
functional diversity that characterizes many intracellular
ubiquitination pathways. While there are numerous struc-
tures of isolated E2 enzymes and E3 ligases, there are rel-
atively few structures of E2:E3 complexes. The structures
of two RING/U-box domains in complex with E2
enzymes have been solved previously: the Cbl-RING
domain with UbcH7 [30] and the CHIP U-box domains
with Ubc13-Uev1a [22]. In addition, a complex between
the CNOT4 RING domain and UbcH5b was modelled
based on a comprehensive series of NMR and mutagenesis
experiments [34].
We add to the above list the structure of the CHIP U-box:
UbcH5a complex. The CHIP U-box is the first ubiquitin
ligase domain to be structurally characterized with two
different E2 enzymes, shedding additional light on key
specificity determinants that govern E2:E3 interactions. A
number of determinants are conserved among all the
structurally characterized E2:E3 complexes, partly reflect-
ing sequence homology among the ligase-interacting por-
tions of E2 enzymes [14]. Table 3 lists key interactions
found in the complexes, grouping those that are located in
equivalent positions.
The central hydrophobic interface, formed between
aliphatic groups from loops L4 and L7 of the E2 enzyme
and a cluster of aliphatic groups from both structured
loops and the central helix of the RING/U-box domains,
is likely present in all complexes formed between E2
enzymes and RING/PHD-like/U-box ligases. A ring of pri-
marily hydrophobic residues from the L1 and L2 loops
and the central helix of the RING/U-box ligase domains
define the walls of a concavity into which the tip of E2-L4
protrudes. These include a hydrophobic residue on loop
L1 (such as CHIP-I216) that is an isoleucine, leucine or
valine in essentially all RING/U-box domains.
The conformations of the interacting loops on both part-
ners are strongly influenced by the positions of highly
conserved proline residues, which interact directly with
the rim of the hydrophobic concavity on the ligase
domain. These prolines also help to position other E2 res-
idues such as the large hydrophobic sidechain at the tip of
loop L4 (such as UbcH5-F62). Correspondingly, a highly
conserved proline residue on loop L2 of the RING/U-box
type ligases (such as CHIP-P269) helps to position both
hydrophobic and polar residues on this loop for interac-
tions with E2 enzymes. This proline also directly interacts
with the serine and alanine of the E2 S-P-A motif (which
contains a third key proline residue) through its main-
chain carbonyl group and through hydrophobic contacts
respectively. It may be difficult to directly test the impor-
tance of these prolines by mutagenesis, as the correspond-
ing mutants are likely to be improperly folded or
insoluble in bacterial expression systems (data not
shown).
The central hydrophobic interface is flanked by polar
interactions contributed by sidechains from the E2-α1
helix and loop L7. A significant number of these determi-
nants involve sidechain-mainchain interactions. Interest-
ingly, several stacking interactions between arginine
guanidinium groups and aromatic sidechains are present
in the CHIP complexes, and likely play a role in the
UbcH5:CNOT4 complex as well. In addition, an arginine
on loop L2 of the ligase domains (R272 in CHIP) extends
to interact with mainchain groups on loop L7 of the E2
enzymes. Overall these flanking interactions are less con-
served among the E2:E3 interactions of known structure,
and likely among E2:E3 complexes in general, than the
central hydrophobic interaction surface. For example, no
aromatic or hydrophobic residues corresponding to
CHIP-F237 are present in c-Cbl or many other RING/U-
box type ligases. Aromatic residues appear at this position
in only a third of such ligase domains. Similarly, the
flanking arginine (such as CHIP-R272) is conserved in
only some U-boxes and RING domains, although there
Table 2: S-P-A motif conservation in E2 enzymes
E2 enzyme Loop 7 Sequence Interacts w. CHIP? Reference
Ubc1 DQWAAA N [20]
UbcH2 QTWTAL N [20]
Ubc3 ERWNPTN [ 1 8 ,  2 0 ]
UbcH7 ENWKPA N [18, 20]
UbcH8 ENWKPCN [ 1 8 ]
UbcH5a-c SQWSPA Y[ 2 0 ]
Ubc13 DKWSPA Y [22, 24]
Ube2e1-3 DNWSPA Y*
Residues on loop 7 of selected E2 enzymes, corresponding to the positions of the S-P-A motifs in UbcH5 and Ubc13.
*Reported in this study.BMC Structural Biology 2008, 8:26 http://www.biomedcentral.com/1472-6807/8/26
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are often other polar residues with long sidechains at this
position.
The relative importance of individual interactions in
determining the overall affinity differs among E2:E3 com-
plexes. For example, the CHIP-R272A and F237A mutants
promote polyubiquitin formation by Ubc13 but do not
interact productively with UbcH5 (Figure 4). Similarly,
Ubc13 retains its interaction with CHIP even when M64,
the hydrophobic residue on loop Ubc13-L4 that points
into the hydrophobic pocket of the CHIP U-box, is
mutated to alanine. This residue is a tyrosine or phenyla-
lanine in approximately half of E2 enzymes, and hydro-
phobic in another 25%, but polar in the remaining E2
enzymes. This residue is somewhat less conserved than is
the hydrophobic character of its binding pocket on the
RING/U-box domain surface. This suggests that several
other residues, such as the conserved prolines on E2-L4
and L7, can provide enough hydrophobic interaction area
to support some E2:E3 interactions, depending on
whether other supporting interactions are present.
CHIP binds 3- to 5-fold more strongly to uncharged
Ubc13 than UbcH5a in isothermal titration calorimetric
measurements, although both affinities are in the micro-
molar range ([22]; Z.X. and S.M., unpublished data). This
suggests that the total binding energies are similar in the
two complexes but are distributed differently among indi-
vidual interactions in the binding interfaces. For example,
a salt bridge is present between Ubc13-α1 and CHIP-L1
that has no counterpart in the UbcH5:CHIP complex (Fig-
ure 3B). The relative insensitivity of Ubc13-Uev1a to sin-
gle mutations in the CHIP hydrophobic interface may
also reflect the slightly higher affinity of this E2:E3 com-
plex. It remains to be seen whether the affinity of CHIP for
the ubiquitin-loaded forms of Ubc13 and UbcH5 are sim-
ilar. We will also be investigating whether we can disrupt
Ubc13:CHIP interactions by combining two Ubc13 muta-
tions that, by themselves, do not disrupt interaction with
CHIP.
A preponderance of hydrophobic and sidechain-main-
chain interactions, rather than sidechain-sidechain inter-
actions, promotes the close apposition of the interacting
surfaces in the CHIP:UbcH5a and CHIP:Ubc13 com-
plexes. This highlights the role that the avoidance of steric
clashes may play in E2:E3 interaction selectivity. The S-P-
A motif, which appears to be required for interaction with
the CHIP U-box, provides an example of both negative
steric selectivity and positive interaction selectivity, since
the serine side chain forms a key hydrogen bond with a
mainchain proline carbonyl group from the U-box. Sub-
stitution of the serine with an alanine, as in Ubc1, pre-
vents the E2 enzyme from productively interacting with
CHIP interactions with Ube2e2 and UbcH7 Figure 5
CHIP interactions with Ube2e2 and UbcH7. A. Autoubiquitination of CHIP in the presence of Ube2e2 catalytic domain 
(Ube2e2-cat) probed by western blotting. Anti-ubiquitin staining confirms the formation of polyubiquitin chains. Anti-CHIP 
staining shows that a fraction of CHIP is modified by mono- and polyubiquitin, migrating as higher-molecular weight bands. B. 
In vitro ubiquitination measurements of CHIP with Ube2e2 and UbcH7 carried out using the ELISA-based assay. His-CHIP 
bound to Nickel-NTA coated microplates was autoubiquitinated with FLAG-Ubiquitin in the presence of E2 enzymes as 
shown. UbcH5b was used as the positive control; a reaction containing UbcH5b but no His-CHIP was used as a negative con-
trol ("-CHIP"). Counts were normalized by the value measured for the positive control.BMC Structural Biology 2008, 8:26 http://www.biomedcentral.com/1472-6807/8/26
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CHIP [18,20]. Other E2 enzymes that have bulky residues
at positions equivalent to the S-P-A motif are also unable
to interact with CHIP (Table 3).
In the Cbl:UbcH7 complex, a lysine residue replaces the
serine, and the local conformations of the UbcH7-L7 and
Cbl-L2 loops are different than those in the UbcH5a:CHIP
complex, contributing to different polar interactions and
accommodating the larger lysine side chain [30]. The N-
terminal helix and loops L4 and L7 have slightly different
conformations in UbcH7 than their counterparts in
UbcH5a and Ubc13, possibly preventing them from ori-
enting the relevant groups correctly to partner with the
CHIP U-box. For example, the key E2-α1 arginine residue
(such as UbcH5a-R5) interacts with a different loop L1
mainchain carbonyl in the Cbl:UbcH7 and
CNOT4:UbcH5b complexes than in the CHIP complexes
(Table 3). An inability to form this hydrogen bond may be
the reason why the UbcH7-K96S mutant did not interact
productively with CHIP (Figure 5B). Superimposition of
UbcH7 onto the UbcH5a:CHIP U-box structure also sug-
gests that UbcH7-R6, the equivalent of UbcH5a-R5,
would clash with CHIP-F227, while Cbl has an alanine
residue at the position corresponding to CHIP-F227 (data
not shown). Interestingly, Cbl has been shown to interact
with both UbcH7 and UbcH5 [35]. In addition, Cbl
engages E2 enzymes not only through the RING domain
but also through a secondary binding site between a heli-
cal region and the N-terminal helix of the E2 enzymes
[30]. This may compensate for the absence of an interac-
tion equivalent to the UbcH5a-R5: CHIP-F227 interac-
tion.
The number and similarity of some of the specificity deter-
minants among the known E2:E3 complexes suggests that
many E3 ligases interact with more than one type of E2
enzyme. This has several potential functional conse-
quences. One possibility is that an E3 ligase interacts with
different E2 enzymes in different intracellular contexts.
We found that CHIP interacts in vitro with a representative
Class III E2 enzyme, Ube2e2. Ube2e2 and its close homo-
logues Ube2e1 and Ube2e3 undergo nuclear import after
they are charged with ubiquitin [33]. CHIP is partially
localized to the nucleus [36], suggesting that CHIP may be
a partner for these Class III E2 enzymes in the ubiquitina-
tion of nuclearly localized substrates.
Another rationale for the ability of an E3 ligase to interact
with multiple E2 enzymes is specific to Ubc13. Ubc13 is
the only E2 enzyme that exclusively synthesizes K63-
linked polyubiquitin chains, in a manner dependent on
its heterodimerization with a UEV (Ubiquitin E2 variant)
protein, such as Uev1a, Uev1b or Mms2 [25,37]. UEVs
have an E2-like fold but lack a catalytic cysteine. Instead,
they bind ubiquitin noncovalently and position K63 of
the noncovalently bound ubiquitin for conjugation to the
thioester-linked ubiquitin on Ubc13, thus forming K63-
linked polyubiquitin [38,39]. Ubc13/UEV heterodimers
may be unable to directly ubiquitinate some substrates,
instead forming free K63-linked chains [24,40]. Accumu-
lating evidence, however, suggests that Ubc13/UEV het-
erodimers may also bind to a substrate-conjugated
ubiquitin moiety through the UEV subunit [41]. This
could allow Ubc13 to attach additional ubiquitins to the
initial ubiquitin, forming a substrate-conjugated K63-
linked chain. Ubc13/UEV heterodimers may thus rely on
Table 3: Key interactions in structurally characterized E2:E3 complexes
E2:E3 Complex [PDB:ID Code]
Interaction E2: E3 Cbl:UbcH7 [PDB:1FBV] CNOT4:UbcH5 
[PDB:1UR6]
CHIP:UbcH5 
[PDB:2OXQ]
CHIP:Ubc13 
[PDB:2C2V]
E2-α1: E3-L1
Arg:mainchain R6:K382O precedes I383) R5:P15O precedes L16) R5:I235O R7:I235O
Arg:sidechain R5:M18 R5:F237 (stacking) R7:F237 (stacking)
salt bridges K4:E19/K4:E13 K8:E13 R14:D229
sidechain: mainchain K8:F237O K10:F237O
E2-L4/L7: E3-α/L1/L2
hydrophobic P62/F63/P97/A98:I383/
W408/P417/F418
P61/F62/P95/A96:L16/I45/
E49/L52/P54
P61/F62/P95/A96:I235/
H260/V264/P269/V270
P63/M64/P97/A98:I235/
H260/R263/V264/P269/V270
E2-L4:E3-α polar F62:R44 (stacking) Q92: 
E49
F62:R263 (stacking)
E2-L4:E3-α salt bridges D59:R44 K68: D48/E49
E2-L7: E3-L2 polar
S-P-A:mainchain A98N:P417O K96:F418O S96:P54O S94:P269O S96:P269O
mainchain:Arg E93O:R420 Q92O:R57 Q92O:R272 K94O:R272
Key interactions observed in structures of E2:E3 complexes [22, 30, 34]. The CNOT4:UbcH5 complex structure was not solved explicitly but 
modeled based on NMR structures of CNOT4 and UbcH5 and on experimental restraints derived from NMR data and mutagenesis [34].BMC Structural Biology 2008, 8:26 http://www.biomedcentral.com/1472-6807/8/26
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other E2 enzymes, which must be compatible with the E3
ligase participating in the ubiquitination reaction, to
"preubiquitinate" a given substrate. Ubc13-Uev1a and
Ubc13-Mms2 participate in distinct intracellular proc-
esses with different intracellular localization [42]. Intrac-
ellular localization may further limit which
preubiquitinating E2 enzymes are available. If the preu-
biquitinating E2 enzyme is itself capable of polyubiquiti-
nation, the relative affinities of the preubiquitinating E2
enzyme and Ubc13 for the E3 ligase may also regulate the
type of polyubiquitin chain that is added to the substrate,
as both E2 enzymes may compete for binding to the E3
ligase.
Conclusion
In this article, we describe the structural basis for the inter-
action of the U-box of CHIP with its cognate E2 enzyme
UbcH5a. Binding of CHIP to UbcH5a and Ubc13
enzymes is mediated by a similar set of interacting groups,
which resemble those observed in other structurally char-
acterized RING:E2 enzyme complexes. The CHIP:UbcH5a
complex forms through close packing of complementary
hydrophobic surfaces, surrounded by polar interactions.
The S-P-A motif, located on loop L7 of UbcH5a and
Ubc13 acts as an important specificity determinant; E2
enzymes lacking this motif are not cognate enzymes for
CHIP. Based on the conservation of the S-P-A motif, the
Class III E2 enzyme Ube2e2 and its homologues Ube2e1
and Ube2e3 are also cognate E2 enzymes for CHIP. CHIP
may have to interact sequentially other E2 enzymes and
Ubc13-Uev1a in order to attach K63-linked polyubiquitin
chains on substrates, as CHIP only stimulates the forma-
tion of free K63-polyubiquitin by Ubc13-Uev1a. This pro-
vides one functional rationale for the ability of CHIP and
other E3 ligases to interact with multiple E2 enzymes.
Methods
Protein expression and purification
For crystallization trials, Zebrafish (Brachydanio rerio)
CHIP residues 204–284 (encompassing the U-box) and
UbcH5a were cloned into pHis||2 vector [43] and
expressed as His-tagged fusion proteins in E. coli
Rosetta2(DE3) cells (Novagen) at 20°C for 16 hours after
induction with 0.5 mM IPTG. The proteins were purified
by Nickel affinity chromatography in 50 mM Sodium
Phosphate pH 7.7, and 300 mM NaCl. After overnight
cleavage with Tobacco Etch Virus (TEV) protease, cleaved
His-tags were removed using a second round of Nickel-
affinity chromatography. Additional purification was per-
formed by Superdex 75 gel filtration column in 50 mM
Tris pH 7.6, 150 mM NaCl.
For in vitro ubiquitination assays, human CHIP, Ubc13,
and UbcH7 were cloned into the pHis||2 vector and
expressed as above. Submilligram quantities of His-tagged
CHIP were purified using a protein miniprep kit (His-Spin
kit, Zymo Research) and used for subsequent assays with-
out removal of the His-tags. Larger quantities of His-
tagged CHIP, Ubc13 and UbcH7 were purified by Nickel
affinity chromatography as described above, except that
buffers were at pH 7.4 (CHIP and Ubc13) or pH 7.8
(UbcH7). Human UbcH5b and Uev1a were cloned into
pGST||2 vector, expressed as glutathione S-transferase
(GST) fusion proteins, and purified by glutathione-sepha-
rose chromatography in 150 mM NaCl and 50 mM
sodium phosphate, pH 7.8. GST tags were removed by
overnight cleavage with TEV protease during dialysis in
100 mM NaCl, 50 mM sodium phosphate pH 7.0, 5 mM
2-mercaptoethanol, followed by a second pass over the
glutathione resin.
Site-directed mutations were introduced into full-length
His-tagged human CHIP or the E2 enzymes using the
QuickChange mutagenesis kit (Stratagene) and verified
by sequencing. His-tagged CHIP mutants were bacterially
expressed similarly to the wild type protein and purified
at small scales using the His-spin protein miniprep kit
(Zymo Research). E2 enzyme mutants were expressed as
GST-fusions and purified like GST-tagged Uev1a with
appropriately adjusted buffer pH values. Expression and
purity of the mutants were quantified by SDS-PAGE.
Crystallization, structure determination and refinement
Zebrafish CHIP U-box and UbcH5a were dialyzed into
crystallization buffer (50 mM NaCl, 20 mM Tris-HCl
(pH7.4), 2 mM DTT), combined in a 1:1 ratio and incu-
bated at 4°C for 3 hours. The complex was crystallized at
20 mg/mL by hanging-drop vapor-diffusion over 1.65 M
Ammonium Sulfate, 90 mM Bis-Tris (pH 6.7) at 20°C.
Oblong crystals grew to a size of 1 × 0.2 × 0.2 mm3 after
4–5 days. Crystals were cryoprotected in reservoir solution
supplemented with 20% glycerol and frozen in liquid
nitrogen. Native data sets were collected at Advanced
Light Source beamline 4.2.2., Lawrence Berkeley National
Laboratory. Data were indexed, integrated and scaled
using D*TREK [44]. Molecular replacement trials in
Phaser [45] and CNS [46] using a combination of previ-
ously solved structures of the Zebrafish CHIP U-box
[PDB:2F42] and human UbcH5b [PDB:2ESK] were suc-
cessful. After model rebuilding using COOT [47], refine-
ment against a 2.9 Å dataset in CNS resulted in a final
model with R = 0.240, Rfree = 0.272, and no Ramachan-
dran violations as judged by Procheck [48]. Crystallo-
graphic data collection and refinement statistics are
summarized in Table 1. Molecular graphics were gener-
ated using PyMol 0.99 [49].
In vitro ubiquitination assays
Ubiquitination assays subject to subsequent western blot-
ting were performed following the protocol of MurataBMC Structural Biology 2008, 8:26 http://www.biomedcentral.com/1472-6807/8/26
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[50] in 50 μl reaction buffer (50 mM Tris pH 7.6, 4 mM
ATP, 2 mM MgCl2, 1 mM DTT). Reactions containing 2 μg
CHIP, 100 ng E1 enzyme (Boston Biochem), 1 μM E2
enzyme and 6 μg bovine ubiquitin (Sigma) were incu-
bated at 30°C for 2 hours and terminated by addition of
SDS-PAGE sample buffer. Western blotting with HRP-
conjugated anti-ubiquitin (Santa Cruz Biotechnology)
was used to identify ubiquitinated species. Selected blots
were probed with anti-CHIP (Calbiochem) and HRP-con-
jugated goat anti-rabbit antibody.
ELISA-based ubiquitination assays were carried out by a
similar protocol as described by Huang and coworkers
[51]. Reactions were performed in Ni-NTA coated micro-
plates (Pierce His-grab) in 100 μL reaction buffer (50 mM
Tris pH 7.6, 50 mM Imidazole, 3.3 mM ATP, 25 mM
MgCl2, 1 mM DTT). Plates were preblocked with Protein
free Phosphate Buffered Saline (PBS) blocking buffer
(Pierce) to prevent nonspecific binding. Reactions con-
tained 5 μg His-tagged or untagged CHIP, 50 ng E1
enzyme (Boston Biochem), 1 μM untagged E2 enzyme, 1
μg Flag-tagged ubiquitin (Boston Biochem) and, in select
experiments, 0.2 μg His-tagged ubiquitin (Boston Bio-
chem). Reactions were incubated at 30°C for 2 hours and
washed 3 times with 1 × PBS. Anti-Flag antibody and
Horseradish Peroxidase (HRP)-conjugated anti-mouse
secondary antibody were used to detect Flag-ubiquiti-
nated His-tagged CHIP or mixed His-tagged/Flag-tagged
polyubiquitin retained on the Ni-NTA coated plates.
Unbound antibodies were removed with 3 additional PBS
washes followed by addition of 100 μL luminol substrate
(Pierce). Luminescence was measured on a Veritas micro-
plate luminometer (Turner Bioystems). Data from 3–6
independent trials were averaged.
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